- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07937917
Transcutaneous Spinal Cord Stimulation for Motor Recovery After Spinal Cord Injury
Restoring Upper and Lower Extremity Functions in Persons With Spinal Cord Injury by Transcutaneous Spinal Cord Stimulation
This study will examine the safety, feasibility, and potential benefits of transcutaneous spinal cord stimulation (scTS) combined with activity-based training in people with spinal cord injury.
The study will include 10 adults with chronic, incomplete spinal cord injury. Electrical stimulation will be delivered through electrodes placed on the skin over different regions of the spinal cord, while participants perform exercises involving the arms, hands, trunk, and legs.
Participants will undergo initial assessments, individualized stimulation mapping, and 80 training sessions, followed by final assessments. Researchers will evaluate changes in motor function, muscle activity, psychological well-being, autonomic function, and quality of life. Safety and tolerability will also be monitored throughout the study.
Study Overview
Status
Intervention / Treatment
Detailed Description
This prospective, single-arm, within-subject exploratory study will enroll 10 adults aged 18-65 years with chronic incomplete cervical or thoracic spinal cord injury.
The study includes four phases: (1) baseline assessments over approximately two months; (2) stimulation mapping and optimization over approximately 0.5-1 month to identify individualized stimulation parameters; (3) 80 sessions of multisegment transcutaneous spinal cord stimulation combined with activity-based training, delivered 3-5 days per week over approximately 4-7 months; and (4) follow-up assessments.
The intervention targets upper and lower extremity function, trunk control, standing, and stepping. Motor performance will be assessed primarily using the Neuromuscular Recovery Scale (NRS). Additional assessments will examine muscle activation using electromyography (EMG), psychological symptoms, autonomic function, neurological status, spasticity, functional independence, and quality of life.
Intermediate assessments will be conducted during the intervention, including after 40 training sessions. Safety, adverse events, and feasibility will be evaluated throughout the study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Amihai Gottlieb, Ph.D
- Phone Number: +972543323180
- Email: amihai.gottlieb@gmail.com
Study Locations
-
-
-
Ramat Gan, Israel
- Sheba Medical Center
-
Contact:
- Amihai Gottlieb
- Phone Number: +972543323180
- Email: amihai.gottlieb@gmail.com
-
Sub-Investigator:
- Einat Haber, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 18 years of age.
- Non-progressive cervical or thoracic (>T10) spinal cord injury (SCI), with the ability to voluntarily move at least three joints below the injury level.
- At least 6 months post spinal cord injury.
- Stable medical condition.
- Neuromuscular Recovery Scale (NRS) score <4C on any upper extremity, trunk, or standing/stepping item.
Exclusion Criteria:
- Ventilator dependence.
- Untreated or unstable fracture or pressure ulcer.
- Untreated psychiatric disorder or ongoing drug abuse.
- Cardiac, respiratory, bladder, renal, or other medical disorder that may interfere with the study.
- Skeletal muscle Botox injections within the previous 6 months.
- Previous nerve or tendon transfer of the arms or legs.
- Any implanted pump (e.g., baclofen pump or pain pump).
- Unable or unwilling to discontinue anti-spasticity medications.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multisegment scTS + Activity-Based Training
Participants will receive individualized multisegment transcutaneous spinal cord stimulation (scTS) combined with activity-based training targeting upper and lower extremity function, trunk control, standing, and stepping. The intervention will consist of 80 training sessions, delivered 3-5 days per week over approximately 4-7 months, with sessions lasting up to 2 hours. |
Non-invasive electrical stimulation delivered through surface electrodes placed over multiple spinal levels using the NeoStim-5 system. Stimulation sites and parameters will be individually optimized to facilitate motor activation of the upper extremities, trunk, and lower extremities during activity-based training. Individualized, task-specific rehabilitation training targeting voluntary control of the hands, arms, trunk, and legs, including seated activities, standing, and stepping. Training will be provided by rehabilitation staff and combined with transcutaneous spinal cord stimulation. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor Function (NRS)
Time Frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in motor performance assessed using the Neuromuscular Recovery Scale (NRS), which evaluates movement quality and the level of assistance required during upper extremity, trunk, standing, and stepping tasks. Changes in individual task ratings will be assessed across study time points. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Safety
Time Frame: From enrollment through the final study assessment (approximately 7-10 months per participant).
|
Incidence of adverse events and equipment-related complications during the study. Adverse events will be categorized by severity, relatedness to study procedures, and expectedness. |
From enrollment through the final study assessment (approximately 7-10 months per participant).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Surface EMG Amplitude During Functional Motor Tasks
Time Frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in surface electromyography (EMG) signal amplitude during functional motor tasks involving upper extremity, trunk, and lower extremity muscles. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Depression (PHQ-9)
Time Frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in depressive symptoms measured using the 9-item Patient Health Questionnaire (PHQ-9). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Anxiety (GAD-7)
Time Frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in anxiety symptoms measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
PTSD (PCL-5)
Time Frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
|
Changes in self-reported post-traumatic stress symptoms measured using the PTSD Checklist for DSM-5 (PCL-5). Total scores range from 0 to 80, with higher scores indicating greater symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
|
|
PTSD (CAPS-5)
Time Frame: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
Changes in clinician-rated post-traumatic stress symptom severity measured using the CAPS-5. The total severity score ranges from 0 to 80, with higher scores indicating greater symptom severity. |
Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
|
|
Change in ISNCSCI Total Motor Score
Time Frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in motor function assessed using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The total motor score ranges from 0 to 100, with higher scores indicating better motor function. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Modified Ashworth Scale (MAS) Score
Time Frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in muscle spasticity assessed by a clinician using the Modified Ashworth Scale, which grades resistance to passive movement. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) Score
Time Frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in the self-reported impact of spasticity on daily activities, assessed using the SCI-SET questionnaire covering the preceding seven days. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) Questionnaire Score
Time Frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in frequency and severity of symptoms associated with blood pressure instability, assessed using the 24-item ADFSCI questionnaire. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Modified Functional Reach Test Distance
Time Frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in maximum forward reaching distance while seated, measured using the Modified Functional Reach Test |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
|
Change in Activity-Based Balance Level (ABLE) Sitting Subscale Score
Time Frame: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Change in sitting balance assessed using the seven items of the ABLE sitting subscale, with a maximum score of 32. |
Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA-26-3283-GZ-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.